Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 27, 2012 Filed Dec 13, 2012 21:28 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
GiftCommon Stock, $0.10 par value | 100,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-12-064463 · rrd363264.xml · nonDerivative · entry 3 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Indirect · By C. Elliott Sigal 2012 Irrevocable Trust Disclosed balance after: 100,315 F2 · shares: On November 27, 2012, the reporting person contributed a 40% interest in SFI to the C. Elliott Sigal 2012 Irrevocable Trust for the benefit of the reporting person's wife and their children. The reporting person's wife serves as a co-trustee. The reporting person retains a 20% interest in SFI. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose. F2 · ownership.nature: On November 27, 2012, the reporting person contributed a 40% interest in SFI to the C. Elliott Sigal 2012 Irrevocable Trust for the benefit of the reporting person's wife and their children. The reporting person's wife serves as a co-trustee. The reporting person retains a 20% interest in SFI. Read SEC document |
| November 27, 2012 Filed Dec 13, 2012 21:28 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
GiftCommon Stock, $0.10 par value | 200,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-12-064463 · rrd363264.xml · nonDerivative · entry 2 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Indirect · By Sigal Family Investments, LLC Disclosed balance after: 50,158 F1 · shares: On September 6, 2012, in a transaction exempt from Section 16 (including the reporting requirements) by virtue of Rule 16a-13, the reporting person and his wife contributed their combined interest in 250,788 directly-owned shares to Sigal Family Investments, LLC ("SFI") in exchange for interests in SFI. Following the transaction, the reporting person had direct ownership of 48,052 shares and indirect ownership, together with his wife, of 250,788 shares through SFI. As of September 6, 2012, the reporting person held a 60% interest in SFI and the reporting person's wife held a 40% interest in SFI. The reporting person is the sole manager of SFI. F2 · shares: On November 27, 2012, the reporting person contributed a 40% interest in SFI to the C. Elliott Sigal 2012 Irrevocable Trust for the benefit of the reporting person's wife and their children. The reporting person's wife serves as a co-trustee. The reporting person retains a 20% interest in SFI. F3 · shares: On November 27, 2012, the reporting person's wife contributed her 40% interest in SFI to the Ruth L. Sigal 2012 Irrevocable Trust for the benefit of the reporting person and their children. F1 · balance_after: On September 6, 2012, in a transaction exempt from Section 16 (including the reporting requirements) by virtue of Rule 16a-13, the reporting person and his wife contributed their combined interest in 250,788 directly-owned shares to Sigal Family Investments, LLC ("SFI") in exchange for interests in SFI. Following the transaction, the reporting person had direct ownership of 48,052 shares and indirect ownership, together with his wife, of 250,788 shares through SFI. As of September 6, 2012, the reporting person held a 60% interest in SFI and the reporting person's wife held a 40% interest in SFI. The reporting person is the sole manager of SFI. F2 · balance_after: On November 27, 2012, the reporting person contributed a 40% interest in SFI to the C. Elliott Sigal 2012 Irrevocable Trust for the benefit of the reporting person's wife and their children. The reporting person's wife serves as a co-trustee. The reporting person retains a 20% interest in SFI. F1 · ownership.direct: On September 6, 2012, in a transaction exempt from Section 16 (including the reporting requirements) by virtue of Rule 16a-13, the reporting person and his wife contributed their combined interest in 250,788 directly-owned shares to Sigal Family Investments, LLC ("SFI") in exchange for interests in SFI. Following the transaction, the reporting person had direct ownership of 48,052 shares and indirect ownership, together with his wife, of 250,788 shares through SFI. As of September 6, 2012, the reporting person held a 60% interest in SFI and the reporting person's wife held a 40% interest in SFI. The reporting person is the sole manager of SFI. F1 · ownership.nature: On September 6, 2012, in a transaction exempt from Section 16 (including the reporting requirements) by virtue of Rule 16a-13, the reporting person and his wife contributed their combined interest in 250,788 directly-owned shares to Sigal Family Investments, LLC ("SFI") in exchange for interests in SFI. Following the transaction, the reporting person had direct ownership of 48,052 shares and indirect ownership, together with his wife, of 250,788 shares through SFI. As of September 6, 2012, the reporting person held a 60% interest in SFI and the reporting person's wife held a 40% interest in SFI. The reporting person is the sole manager of SFI. Read SEC document |
| November 20, 2012 Filed Nov 20, 2012 21:48 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $32.04 | $320,400.00 |
DisclosureSEC source: 0001225208-12-023590 · doc4.xml · nonDerivative · entry 2 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 940,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $31.89 to $32.18, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 19, 2012 Filed Nov 20, 2012 21:48 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $31.90 | $319,000.00 |
DisclosureSEC source: 0001225208-12-023590 · doc4.xml · nonDerivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 950,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $31.80 to $32.02, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 14, 2012 Filed Nov 15, 2012 21:18 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $31.65 | $316,500.00 |
DisclosureSEC source: 0001225208-12-023243 · doc4.xml · nonDerivative · entry 2 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 960,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $31.40 to $31.86, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 13, 2012 Filed Nov 15, 2012 21:18 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $32.04 | $320,400.00 |
DisclosureSEC source: 0001225208-12-023243 · doc4.xml · nonDerivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 970,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $31.76 to $32.19, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 06, 2012 Filed Nov 6, 2012 22:15 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $33.27 | $332,700.00 |
DisclosureSEC source: 0001225208-12-022538 · doc4.xml · nonDerivative · entry 2 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 980,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $33.05 to $33.43, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 05, 2012 Filed Nov 6, 2012 22:15 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $33.11 | $331,100.00 |
DisclosureSEC source: 0001225208-12-022538 · doc4.xml · nonDerivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $33.00 to $33.21, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 02, 2012 Filed Nov 5, 2012 21:13 UTC |
Cuss Francis MSVP Research
|
Exercise / conversionRestricted Stock Units · Derivative | 6,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-022364 · doc4.xml · derivative · entry 3 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,332 Underlying: Common Stock, $0.10 par value · 6,668 shares Expires 2014-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: Represents vesting of one third of restricted stock units granted on November 2, 2009. The balance of the award is scheduled to to vest in two equal installments on the fourth and fifth anniversaries of the grant date. F3 · derivative.expiration_date: Represents vesting of one third of restricted stock units granted on November 2, 2009. The balance of the award is scheduled to to vest in two equal installments on the fourth and fifth anniversaries of the grant date. Read SEC document |
| November 02, 2012 Filed Nov 5, 2012 21:13 UTC |
Cuss Francis MSVP Research
|
Tax withholdingCommon Stock, $0.10 par value | 3,091 | $33.18 | $102,559.38 |
DisclosureSEC source: 0001225208-12-022364 · doc4.xml · nonDerivative · entry 2 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,598.82 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
| November 02, 2012 Filed Nov 5, 2012 21:13 UTC |
Cuss Francis MSVP Research
|
Exercise / conversionCommon Stock, $0.10 par value | 6,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-022364 · doc4.xml · nonDerivative · entry 1 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,689.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2012 Filed Nov 5, 2012 21:13 UTC |
Elicker John ESVP Pub Affairs & Inv Relation
|
GrantRestricted Stock Units · Derivative | 1,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-022365 · doc4.xml · derivative · entry 1 Elicker John E · CIK 0001554788 · SVP Pub Affairs & Inv Relation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,484 Underlying: Common Stock, $0.10 par value · 1,484 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F2 · derivative.exercise_date: The restricted stock units vest in three equal installments beginning on November 1, 2015. F2 · derivative.expiration_date: The restricted stock units vest in three equal installments beginning on November 1, 2015. Read SEC document |
| October 26, 2012 Filed Oct 29, 2012 21:03 UTC |
Elicker John ESVP Pub Affairs & Inv Relation
|
SaleCommon Stock, $0.10 par value | 2,214 | $33.55 | $74,279.70 |
DisclosureSEC source: 0001225208-12-021952 · doc4.xml · nonDerivative · entry 1 Elicker John E · CIK 0001554788 · SVP Pub Affairs & Inv Relation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,696.97 F1 · balance_after: Includes dividends reinvested. Read SEC document |
| October 23, 2012 Filed Oct 24, 2012 20:18 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $33.26 | $332,600.00 |
DisclosureSEC source: 0001225208-12-021710 · doc4.xml · nonDerivative · entry 2 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $33.10 to $33.67, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 22, 2012 Filed Oct 24, 2012 20:18 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $33.81 | $338,100.00 |
DisclosureSEC source: 0001225208-12-021710 · doc4.xml · nonDerivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,010,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $33.60 to $33.94, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 17, 2012 Filed Oct 18, 2012 20:18 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $34.34 | $343,400.00 |
DisclosureSEC source: 0001225208-12-021509 · doc4.xml · nonDerivative · entry 2 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,020,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $34.25 to $34.44, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 16, 2012 Filed Oct 18, 2012 20:18 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $34.15 | $341,500.00 |
DisclosureSEC source: 0001225208-12-021509 · doc4.xml · nonDerivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,030,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $34.02 to $34.33, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 12, 2012 Filed Oct 15, 2012 20:27 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $33.08 | $330,800.00 |
DisclosureSEC source: 0001225208-12-021334 · doc4.xml · nonDerivative · entry 2 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,040,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $32.99 to $33.29, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 11, 2012 Filed Oct 15, 2012 20:27 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $33.06 | $330,600.00 |
DisclosureSEC source: 0001225208-12-021334 · doc4.xml · nonDerivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $32.94 to $33.38, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 03, 2012 Filed Oct 4, 2012 20:06 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $33.53 | $335,300.00 |
DisclosureSEC source: 0001225208-12-020970 · doc4.xml · nonDerivative · entry 2 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,060,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $33.39 to $33.69, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 03, 2012 Filed Oct 4, 2012 20:07 UTC |
Schmukler Louis SPres., Global Manufacturing &
|
Exercise / conversionRestricted Stock Units · Derivative | 13,933 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-020972 · doc4.xml · derivative · entry 3 Schmukler Louis S · CIK 0001530894 · Pres., Global Manufacturing & 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,868 Underlying: Common Stock, $0.10 par value · 13,933 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: Represents vesting of one third of restricted stock units granted on October 3, 2011. The balance of the award is scheduled to vest in two equal installments on the second and third anniversaries of the grant date. F3 · derivative.expiration_date: Represents vesting of one third of restricted stock units granted on October 3, 2011. The balance of the award is scheduled to vest in two equal installments on the second and third anniversaries of the grant date. Read SEC document |
| October 03, 2012 Filed Oct 4, 2012 20:07 UTC |
Schmukler Louis SPres., Global Manufacturing &
|
Tax withholdingCommon Stock, $0.10 par value | 4,114 | $33.56 | $138,065.84 |
DisclosureSEC source: 0001225208-12-020972 · doc4.xml · nonDerivative · entry 2 Schmukler Louis S · CIK 0001530894 · Pres., Global Manufacturing & 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,819 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
| October 03, 2012 Filed Oct 4, 2012 20:07 UTC |
Schmukler Louis SPres., Global Manufacturing &
|
Exercise / conversionCommon Stock, $0.10 par value | 13,933 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-020972 · doc4.xml · nonDerivative · entry 1 Schmukler Louis S · CIK 0001530894 · Pres., Global Manufacturing & 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2012 Filed Oct 4, 2012 20:06 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $33.88 | $338,800.00 |
DisclosureSEC source: 0001225208-12-020970 · doc4.xml · nonDerivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,070,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $33.75 to $34.11, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 01, 2012 Filed Oct 3, 2012 20:17 UTC |
Heller Frances KSVP, Business Development
|
GrantRestricted Stock Units · Derivative | 17,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-020839 · doc4.xml · derivative · entry 1 Heller Frances K · CIK 0001441724 · SVP, Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,806 Underlying: Common Stock, $0.10 par value · 17,806 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on October 1, 2013. F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on October 1, 2013. Read SEC document |
| September 30, 2012 Filed Oct 1, 2012 20:06 UTC |
CORNELIUS JAMES MDirector
|
GrantCommon Stock, $0.10 par value | 740 | $33.75 | $24,975.00 |
DisclosureSEC source: 0001225208-12-020330 · doc4.xml · nonDerivative · entry 3 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,080,451 F4 · shares: Shares awarded to Mr. Cornelius for service as the Non-Executive Chairman. Read SEC document |
| September 30, 2012 Filed Oct 2, 2012 21:20 UTC |
GROBSTEIN MICHAELDirector
|
GrantDeferred Share Units · Derivative | 298.06 | $33.76 | $10,062.51 |
DisclosureSEC source: 0001225208-12-020688 · doc4.xml · derivative · entry 1 GROBSTEIN MICHAEL · CIK 0001222342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,987.81 Underlying: Common Stock, $0.10 par value · 298.06 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2012 Filed Oct 2, 2012 21:21 UTC |
Storch Gerald LDirector
|
GrantDeferred Share Units · Derivative | 851.6 | $33.76 | $28,750.02 |
DisclosureSEC source: 0001225208-12-020689 · doc4.xml · derivative · entry 1 Storch Gerald L · CIK 0001205004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,727.44 Underlying: Common Stock, $0.10 par value · 851.6 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 28, 2012 Filed Oct 1, 2012 20:06 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $33.75 | $337,500.00 |
DisclosureSEC source: 0001225208-12-020330 · doc4.xml · nonDerivative · entry 2 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,079,711 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $33.64 to $33.87, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 27, 2012 Filed Oct 1, 2012 20:06 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $33.88 | $338,800.00 |
DisclosureSEC source: 0001225208-12-020330 · doc4.xml · nonDerivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,089,711 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $33.77 to $33.98, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 19, 2012 Filed Sep 20, 2012 20:11 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $32.97 | $329,700.00 |
DisclosureSEC source: 0001225208-12-019998 · doc4.xml · nonDerivative · entry 3 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,099,711 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $32.87 to $33.09, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 18, 2012 Filed Sep 20, 2012 20:11 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $32.98 | $329,800.00 |
DisclosureSEC source: 0001225208-12-019998 · doc4.xml · nonDerivative · entry 2 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,109,711 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $32.87 to $33.13, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 13, 2012 Filed Sep 20, 2012 20:11 UTC |
CORNELIUS JAMES MDirector
|
GiftCommon Stock, $0.10 par value | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-019998 · doc4.xml · nonDerivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,119,711 Read SEC document |
| September 07, 2012 Filed Sep 7, 2012 20:11 UTC |
Caldarella Joseph CSVP & Controller
|
Exercise / conversionOption (right to buy) · Derivative | 16,500 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0001225208-12-019254 · doc4.xml · derivative · entry 5 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 16,500 shares Expires 2014-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 2, 2004. Read SEC document |
| September 07, 2012 Filed Sep 7, 2012 20:11 UTC |
Caldarella Joseph CSVP & Controller
|
SaleCommon Stock, $0.10 par value | 15,415 | $33.16 | $511,161.40 |
DisclosureSEC source: 0001225208-12-019254 · doc4.xml · nonDerivative · entry 3 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,659 F1 · shares: Shares sold to cover exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. Read SEC document |
| September 07, 2012 Filed Sep 7, 2012 20:11 UTC |
Caldarella Joseph CSVP & Controller
|
SaleCommon Stock, $0.10 par value | 6,740 | $33.16 | $223,498.40 |
DisclosureSEC source: 0001225208-12-019254 · doc4.xml · nonDerivative · entry 2 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,074 Read SEC document |
| September 07, 2012 Filed Sep 7, 2012 20:11 UTC |
Caldarella Joseph CSVP & Controller
|
Exercise / conversionCommon Stock, $0.10 par value | 16,500 | $28.11 | $463,815.00 |
DisclosureSEC source: 0001225208-12-019254 · doc4.xml · nonDerivative · entry 1 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2012 Filed Sep 7, 2012 20:08 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
Exercise / conversionOption (right to buy) · Derivative | 135,000 | $0.00 Strike: $23.14 | $0.00 |
DisclosureSEC source: 0001225208-12-019252 · doc4.xml · derivative · entry 3 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 135,000 shares Expires 2013-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 4, 2003. Read SEC document |
| September 05, 2012 Filed Sep 7, 2012 20:08 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
SaleCommon Stock, $0.10 par value | 115,500 | $33.05 | $3,817,275.00 |
DisclosureSEC source: 0001225208-12-019252 · doc4.xml · nonDerivative · entry 2 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,991 F1 · shares: Shares sold to cover exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $33.02 to $33.13, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F1 · price: Shares sold to cover exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $33.02 to $33.13, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 05, 2012 Filed Sep 7, 2012 20:08 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 135,000 | $23.14 | $3,123,900.00 |
DisclosureSEC source: 0001225208-12-019252 · doc4.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2012 Filed Sep 7, 2012 20:06 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
OtherCommon Stock, $0.10 par value | 250,788 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-019250 · doc4.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,840 F1 · kind: On September 5, 2012, the reporting person transferred to his wife a 40% pecuniary interest in 250,788 shares of Bristol-Myers Squibb common stock. For purposes of clarity, while the transfer is shown as a disposition, the transfer did not increase or decrease the number of shares reported as beneficially owned by the reporting person. F1 · shares: On September 5, 2012, the reporting person transferred to his wife a 40% pecuniary interest in 250,788 shares of Bristol-Myers Squibb common stock. For purposes of clarity, while the transfer is shown as a disposition, the transfer did not increase or decrease the number of shares reported as beneficially owned by the reporting person. F1 · price: On September 5, 2012, the reporting person transferred to his wife a 40% pecuniary interest in 250,788 shares of Bristol-Myers Squibb common stock. For purposes of clarity, while the transfer is shown as a disposition, the transfer did not increase or decrease the number of shares reported as beneficially owned by the reporting person. F1 · balance_after: On September 5, 2012, the reporting person transferred to his wife a 40% pecuniary interest in 250,788 shares of Bristol-Myers Squibb common stock. For purposes of clarity, while the transfer is shown as a disposition, the transfer did not increase or decrease the number of shares reported as beneficially owned by the reporting person. F2 · ownership.direct: On September 7, 2012, the reporting person and his wife contributed their combined interest in the 250,788 shares to Sigal Family Investments, LLC ("SFI") in exchange for interests in SFI. The reporting person is the sole manager of SFI. The contribution of the shares to SFI effects only a change in the form of the reporting person's beneficial ownership of securities, without increasing or decreasing his pecuniary interest in the securities or transferring a pecuniary interest to another person, and is exempt from Section 16 (including the reporting requirements) by virtue of Rule 16a-13. The reporting person's indirect ownership in the shares contributed to SFI will be reflected on the reporting person's next Section 16 report covering non-derivative securities. Read SEC document |
| August 30, 2012 Filed Sep 4, 2012 20:12 UTC |
Cuss Francis MSVP Research
|
Exercise / conversionOption (right to buy) · Derivative | 32,300 | $0.00 Strike: $22.73 | $0.00 |
DisclosureSEC source: 0001225208-12-018890 · doc4.xml · derivative · entry 7 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 32,300 shares Expires 2016-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 7, 2006. Read SEC document |
| August 30, 2012 Filed Sep 4, 2012 20:12 UTC |
Cuss Francis MSVP Research
|
Exercise / conversionOption (right to buy) · Derivative | 55,463 | $0.00 Strike: $22.14 | $0.00 |
DisclosureSEC source: 0001225208-12-018890 · doc4.xml · derivative · entry 6 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 55,463 shares Expires 2018-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 4, 2008. Read SEC document |
| August 30, 2012 Filed Sep 4, 2012 20:12 UTC |
Cuss Francis MSVP Research
|
Exercise / conversionOption (right to buy) · Derivative | 59,855 | $0.00 Strike: $17.51 | $0.00 |
DisclosureSEC source: 0001225208-12-018890 · doc4.xml · derivative · entry 5 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,952 Underlying: Common Stock, $0.10 par value · 59,855 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second and third anniversaries of the grant date, which was March 3, 2009. The remainder of the stock option award will vest on March 3, 2013, the fourth anniversary of the grant date. Read SEC document |
| August 30, 2012 Filed Sep 4, 2012 20:12 UTC |
Cuss Francis MSVP Research
|
SaleCommon Stock, $0.10 par value | 118,190 | $32.89 | $3,887,269.10 |
DisclosureSEC source: 0001225208-12-018890 · doc4.xml · nonDerivative · entry 4 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,021.82 F1 · price: Shares sold to cover exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $32.86 to $32.92, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 30, 2012 Filed Sep 4, 2012 20:12 UTC |
Cuss Francis MSVP Research
|
Exercise / conversionCommon Stock, $0.10 par value | 32,300 | $22.73 | $734,179.00 |
DisclosureSEC source: 0001225208-12-018890 · doc4.xml · nonDerivative · entry 3 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,211.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2012 Filed Sep 4, 2012 20:12 UTC |
Cuss Francis MSVP Research
|
Exercise / conversionCommon Stock, $0.10 par value | 55,463 | $22.14 | $1,227,950.82 |
DisclosureSEC source: 0001225208-12-018890 · doc4.xml · nonDerivative · entry 2 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,911.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2012 Filed Sep 4, 2012 20:12 UTC |
Cuss Francis MSVP Research
|
Exercise / conversionCommon Stock, $0.10 par value | 59,855 | $17.51 | $1,048,061.05 |
DisclosureSEC source: 0001225208-12-018890 · doc4.xml · nonDerivative · entry 1 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,448.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2012 Filed Aug 28, 2012 20:07 UTC |
Caforio GiovanniPres., US Pharmaceuticals
|
Exercise / conversionOption (right to buy) · Derivative | 30,458 | $0.00 Strike: $23.18 | $0.00 |
DisclosureSEC source: 0001225208-12-018668 · doc4.xml · derivative · entry 3 Caforio Giovanni · CIK 0001533201 · Pres., US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 30,458 shares Expires 2013-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 4, 2003. Read SEC document |
| August 24, 2012 Filed Aug 28, 2012 20:07 UTC |
Caforio GiovanniPres., US Pharmaceuticals
|
SaleCommon Stock, $0.10 par value | 25,900 | $32.69 | $846,671.00 |
DisclosureSEC source: 0001225208-12-018668 · doc4.xml · nonDerivative · entry 2 Caforio Giovanni · CIK 0001533201 · Pres., US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,260.018 F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $32.67 to $32.71, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.